Search results for "Symptomatic"

showing 10 items of 479 documents

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

2018

Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart failure symptoms. In these cases, CVD may seem to be ‘silent’ or ‘asymptomatic’, but may be more accurately characterised as unrecognised diabetic cardiac impairment. An initial step to raise awareness of unrecognised CVD in individuals with T2D would be to reach a consensus regarding the terminology used to describe this phenomenon. By standardising the terminologies, and agreeing on the implementation of an efficient screening program, it is anti…

Blood Glucoselcsh:Diseases of the circulatory (Cardiovascular) systemEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDiseaseType 2 diabetes030204 cardiovascular system & hematologySilent0302 clinical medicineRisk FactorsMass ScreeningAsymptomatic ; Atypical ; Cardiovascular disease ; Screening ; Silent ; Type 2 diabetes ; Unrecognised.Type 2 diabetesCardiovascular diseasePrognosisAsymptomatic3. Good health2712 Endocrinology Diabetes and MetabolismCardiovascular DiseasesScreeningmedicine.symptomCardiology and Cardiovascular Medicinemedicine.medical_specialtyPrognostic factor030209 endocrinology & metabolism610 Medicine & healthRisk AssessmentAsymptomatic2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesPredictive Value of TestsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsIntensive care medicineUnrecognisedbusiness.industrymedicine.diseaseEarly DiagnosisDiabetes Mellitus Type 2lcsh:RC666-7012724 Internal MedicineHeart failureAsymptomatic DiseasesCommentarybusinessAtypicalBiomarkers
researchProduct

Serological screening for Leishmania infantum in asymptomatic blood donors living in an endemic area (Sicily, Italy)

2005

The purpose of our study was to assess whether Leishmania infantum parasitemia occurs in asymptomatic Leishmania-seropositive subjects. Samples from 500 blood donors were tested using an enzyme-linked immunosorbent assay (ELISA). Anti-Leishmania antibodies were not found in any sample. Our findings suggest that the risk of L. infantum transmission by blood transfusion in Sicily is very low.

Blood transfusionmedicine.medical_treatmentAntibodies ProtozoanBlood DonorsParasitemiaAsymptomaticSerologyleishmaniaparasitic diseasesmedicineAnimalsHumansLeishmania infantumbiologyTransmission (medicine)business.industryHematologybiology.organism_classificationmedicine.diseaseVisceral leishmaniasisItalyImmunologybiology.proteinLeishmaniasis VisceralLeishmania infantumAntibodymedicine.symptombusinessTransfusion and Apheresis Science
researchProduct

Helicobacter pyloriinfection among children with gastrointestinal symptoms: a high prevalence of infection among patients with reflux oesophagitis

2007

Aim: To investigate the link between H.pylori infection and dyspepsia in children, and association with reflux oesophagitis. Patients and Methods: H.pylori status was detected by rapid urease test and/or culture in 130 consecutive symptomatic children coming for upper gastrointestinal endoscopy: 40 – aged 8–12 years (55% boys); 90 – aged 13–18 years (21% boys). Endoscopic findings were analyzed. H.pylori prevalence in the age group 8–12 years was compared to the prevalence among 55 asymptomatic children, aged 7–12 years (13C–urea breath test). Statistical analysis: χ2 test, Fisher's test, and logistic regression analysis. Results: The prevalence of H.pylori infection among patients with gas…

Breath testmedicine.medical_specialtybiologymedicine.diagnostic_testbusiness.industryRapid urease testGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseLogistic regressionAsymptomaticGastroenterologyEl NiñoInternal medicinePediatrics Perinatology and Child HealthEpidemiologymedicinemedicine.symptombusinessEsophagitisActa Paediatrica
researchProduct

CD133 expression in placenta chorioangioma presenting as a giant asymptomatic mass

2021

Background: Placental chorioangioma is the most common benign non-trophoblastic neoplasm of the placenta. Its clinical relevance lies in the size of the tumor since larger masses cause pregnancy complications, including an unfavorable neonatal outcome. Case presentation: We report the case of a 34-year-old second gravida and nullipara at the 35th week of gestation, admitted to the gynecological department for antibiotic-resistant fever. The cardiotocography performed during hospitalization showed an abnormal fetal pattern. A 2250 g newborn was delivered by cesarean section. No complications were observed during childbirth and postpartum was insignificant. On gross inspection a white fleshy …

CD31Adultmedicine.medical_specialtyMedicine (General)Placenta Diseasesgiant asymptomatic maPlacentaCase Reportgiant asymptomatic massR5-920PregnancyPlacentamedicineChildbirthCD133 expression; Giant asymptomatic mass; Placental chorioangioma; Adult; Cesarean Section; Endothelial Cells; Female; Humans; Infant Newborn; Placenta; Pregnancy; Hemangioma; Placenta Diseases; Pregnancy Complications NeoplasticHumansClinical significanceCardiotocographyGiant asymptomatic massPregnancyFetusNeoplasticplacental chorioangiomamedicine.diagnostic_testObstetricsbusiness.industryCesarean SectionCD133 expression; Giant asymptomatic mass; Placental chorioangiomaEndothelial CellsInfantGeneral Medicinemedicine.diseaseNewbornPregnancy Complicationsmedicine.anatomical_structurePlacental chorioangiomaembryonic structuresGestationFemaleGiant asymptomatic mabusinessHemangiomaCD133 expression
researchProduct

Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?

2021

Cellular and humoral response to acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections is on focus of research. We evaluate herein the feasibility of expanding virus‐specific T cells (VST) against SARS‐CoV‐2 ex vivo through a standard protocol proven effective for other viruses. The experiment was performed in three different donors' scenarios: (a) SARS‐CoV‐2 asymptomatic infection/negative serology, (b) SARS‐CoV‐2 symptomatic infection/positive serology, and (c) no history of SARS‐CoV‐2 infection/negative serology. We were able to obtain an expanded VST product from donors 1 and 2 (1.6x and 1.8x increase of baseline VST count, respectively) consisting in CD3 + cells (80.3% and 6…

CD4-Positive T-LymphocytesAdoptive cell transferviruses030230 surgerymedicine.disease_causevirus-specific T cellsAsymptomaticSARS‐CoV‐2Serology03 medical and health sciences0302 clinical medicineCOVID‐19medicineCytotoxic T cellHumansRespiratory systemthird‐party donorsCoronavirusTransplantationbusiness.industrySARS-CoV-2COVID-19Original Articlesvirus‐specific T cellsAdoptive Transferlymphocyte expansionrespiratory virusInfectious DiseasesImmunologyRespiratory virus030211 gastroenterology & hepatologyOriginal Articlethird-party donorsmedicine.symptombusinessadoptive immunotherapyEx vivo
researchProduct

Mature teratoma of the uterine corpus with thyroid differentiation

2000

A case of a clinically silent mature teratoma of the uterine corpus is reported. A 55-year-old woman presented with multiple uterine leiomyomas. The discovery was incidental, because the patient was asymptomatic. Macroscopically, a colloid-hemorrhagic-looking nodule was present. Histologic and immunohistochemical studies showed that this tumor was a small thyroid mass. Key words:,

Calcitoninendocrine systemPathologymedicine.medical_specialtymedicine.medical_treatmentThyroid GlandHysterectomyThyroglobulinAsymptomaticPathology and Forensic MedicineImmunoenzyme TechniquesmedicineHumansUterine NeoplasmGynecologyHysterectomyUterine leiomyomabusiness.industryThyroidTeratomaCell DifferentiationNodule (medicine)General MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureUterine NeoplasmsFemaleThyroglobulinTeratomamedicine.symptombusinessPathology International
researchProduct

A multicentre prospective study of prostatic volume in asymptomatic men in various continents.

1997

Objective: To compare prostatic volumes in asymptomatic Asian men with similar controls in Europe. Patients and methods: Six centres (Beijing, Hong Kong, Jinan, Lisbon, Palermo and Stirling) independently selected asymptomatic men aged 55 y or more for assessment of prostatic volume using transrectal ultrasound (total=320 men) between 1992 and 1993. Results: Prostatic volumes in asymptomatic men were greater in Beijing than Hong Kong, Stirling and Palermo (P<0.05) and were smaller in Stirling than Beijing and Jinan (P<0.05). Conclusions: These results suggest that men from Stirling are less likely to have large prostates, but there is no evidence that men from any of the six cities are more…

Cancer ResearchPathologymedicine.medical_specialtybusiness.industryUrologymedicine.diseaseAsymptomaticProstate cancerOncologyBeijingMedicinemedicine.symptombusinessProspective cohort studyDemographyProstate cancer and prostatic diseases
researchProduct

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

2020

BackgroundWe have previously reported significantly longer overall survival (OS) with ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with advanced melanoma, with higher incidences of adverse events (AEs) at 10 mg/kg. This follow-up analysis reports a 5-year update of OS and safety.MethodsThis randomized, multicenter, double-blind, phase III trial included patients with untreated or previously treated unresectable stage III or IV melanoma. Patients were randomly assigned (1:1) to ipilimumab 10 mg/kg or 3 mg/kg every 3 weeks for 4 doses. The primary end point was OS.ResultsAt a minimum follow-up of 61 months, median OS was 15.7 months (95% CI 11.6 to 17.8) at 10 mg/kg and 11.5 mont…

Cancer Researchmedicine.medical_specialty2435[SDV]Life Sciences [q-bio]ImmunologyMedizinIpilimumabrandomized trialsGastroenterologyAsymptomaticlaw.inventionimmunology03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineClinical endpointImmunology and Allergy1506030212 general & internal medicineAdverse effectRC254-282Clinical/Translational Cancer ImmunotherapyPharmacologybusiness.industryIncidence (epidemiology)MelanomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseimmunology; oncology; randomized trials[SDV] Life Sciences [q-bio]Oncology030220 oncology & carcinogenesisoncologyMolecular Medicinemedicine.symptombusinessBrain metastasismedicine.drug
researchProduct

Does endoscopic follow-up improve the outcome of patients with benign gastric ulcers and gastric cancer?

1992

This study investigated whether an endoscopic surveillance program for patients with "benign" gastric ulcers and gastric cancer leads to early detection of neoplasms and improves survival. The clinical course of all patients diagnosed between 1977 and 1986 as having either gastric ulcers or gastric cancer was followed for a minimum of 3 years. Of 597 patients with initially benign gastric ulcers, 452 (76%) returned for the recommended endoscopic follow-up examinations. In eight patients (1.8%), repeated biopsies disclosed malignant neoplasms; four of these patients (0.9%) had become asymptomatic. Survival curves were nearly identical in patients who complied and those who did not. Of 241 pa…

Cancer Researchmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryStomachClinical courseCancerEarly detectionmedicine.diseaseGastroenterologyAsymptomaticdigestive system diseasesEndoscopySurgerymedicine.anatomical_structureOncologyInternal medicineMedicineIn patientmedicine.symptombusinessSurvival analysisCancer
researchProduct

Being candid about Candida airway colonization and clinical outcomes: What can we really learn from unadjusted associations?

2020

Candida sppmedicine.medical_specialtyCross InfectionLung Diseases FungalEpidemiologybusiness.industryHealth PolicyRespiratory SystemPublic Health Environmental and Occupational HealthCandidiasisColony Count MicrobialInfectious DiseasesmedicineHumansColonizationAirwayIntensive care medicinebusinessAsymptomatic InfectionsCandidaAmerican journal of infection control
researchProduct